Depression and Disability in Chronic Kidney Disease in Nigeria: A Case-Control Study
Journal Title: International Neuropsychiatric Disease Journal - Year 2016, Vol 7, Issue 2
Abstract
Aim: The main purpose of this study was to determine the prevalence of depression and disability in Chronic Kidney Disease (CKD) patients and to determine any association between stage of CKD and depression in the University College Hospital, Ibadan. Methods: One hundred and sixty CKD patients were matched by age and gender with 160 subjects from the General Outpatient Department (GOPD). CKD patients were staged according to the study center criteria. The Mini International Neuropsychiatry Interview was used to elicit the diagnosis of depression, and the WHODAS 2.0 to assess disability. The Mann-Whitney U test and the independent t test/ANOVA to compare median and mean WHODAS scores respectively, the Chi square statistics were used in comparing WHODAS scores between the CKD group and the control group and the Wilcoxon test for within group comparisons. All analyses were carried out using (SPSS version 16.0). Results: Prevalence of depression was 17.5% in CKD and 4.4% in control group. There was no significant difference between stages of CKD and depression. Predictors of disability were stages 3 and 4 of CKD OR = 1.9, 95% CI (1-3-3.0), P = .001 and depression OR = 8.5, 95% CI (1.8-38.5), P < .01, after model adjustment. Conclusion: There is a need for effective consultation liaison work in the general medical department in order to assist in early detection and treatment of patients with depression in CKD.
Authors and Affiliations
Victor Olufolahan Lasebikan, Joachim Azegbeobor
Atypical Antipsychotic Prevents and Reverses Negative Symptoms in Models of Schizophrenia
Introduction: Negative symptoms associated with cognitive impairment as a core symptom of schizophrenia with significant poor quality of life and remain an unmet clinical need. Administration of N-methyl-D-aspartate (NMD...
Hypovitaminosis D Showed Gender and Seasonal Variations in Saudi Patients with Multiple Sclerosis
Background: Multiple sclerosis (MS) is a chronic, inflammatory, autoimmune, demyelinating disease affecting the central nervous system. Vitamin D is an immunomodulating factor with potentiality to prevent and treat MS....
The Lived Experiences of Persons with Mental Health Disorders in Public Sector Employment in the Niger Delta Region of Nigeria
Aims: Relative to studies of lived experiences of people with mental health disorders in developed countries, no research has focused on the lived experiences of persons living with mental health disorders in the Niger D...
Diffusion-weighted MR Imaging of the Brain: Correlation of Ischemic Lesion Patterns with ASCO Stroke Subtypes
Background: There are many etiologies for ischemic cerebral stroke. Previous studies have not shown whether specific ischemic lesion patterns on early brain diffusion-weighted imaging (DWI) are associated with specific i...
Subjective Experiences of Antipsychotic Treatment: A Comparison of First- and Second-generation Medications among Patients with Schizophrenia
Aims: The patient’s perspective of antipsychotic treatment has been a relatively neglected area of research. Whether subjective experiences of antipsychotic treatment are better among patients on second-generation antips...